Strand News

Strand Life Sciences Closes Financing Led By Quadria Capital

150 150 Maria Kammerer

February 8, 2018 | Bangalore Strand Life Sciences announced an investment by Quadria Capital, Asia’s leading healthcare focused private equity investor. India-based HealthQuad Fund and Singapore-based Heritas Venture Fund also…

read more

Triesta Unit of HCG to Combine with Strand Life Sciences

150 150 Strand Life Sciences

Strategic initiative creates integrated platform dedicated to next generation precision medicine   January 4, 2018 | Bengaluru, India Healthcare Global Enterprises, Ltd. (HCG:NSE) today announced execution of definitive agreements for…

read more

Strand Life Sciences receives College of American Pathologists (CAP) Re-accreditation

150 150 Strand Life Sciences

Extension of CAP accreditation following a recent inspection of Strand Centre for Genomics and Personalized Medicine Lab in Bangalore   November 21, 2017 | Bangalore, India Strand Life Sciences, India’s…

read more

Strand Life Sciences and Cheers to Life Foundation organize ‘Heritage Walk for a Cause’ for their Spread Pink Spread Courage Campaign

150 150 Strand Life Sciences

October 28, 2017 | New Delhi, India Strand Life Sciences, one of India’s foremost bioinformatics and genomic profiling firms, has launched the “Spread Pink. Spread Courage.” campaign this October to…

read more

Strand Life Sciences to showcase Strand NGS, analysis software for next-generation sequencing data at ASHG 2017

150 150 Strand Life Sciences

Scientists from Strand Life Sciences will demonstrate ‘Strand NGS’, an all-in-one next generation sequencing software at the 67th Annual Meeting of the American Society of Human Genetics (ASHG) to be…

read more

Cancer-causing BRCA Gene Mutations at Least Three Times More Prevalent in India Compared to Western Countries Reveals Study

150 150 Maria Kammerer

Strand Life Sciences today released the findings of their study on Hereditary Breast and Ovarian Cancer Cases in India – Study highlights that BRCA gene mutations are the primary cause…

read more

Strand Life Sciences launches ‘STRAND LB’ – a ground-breaking method for monitoring cancer

150 150 Strand Life Sciences

Strand LB helps monitor lung, breast, colorectal and other cancers for tumor presence, response, and recurrence April 11, 2017 | Bangalore, India According to data from the Indian Council of…

read more

Strand Life Sciences creates another global bioinformatics landmark with Strand Ramanujan

150 150 Strand Life Sciences

Strand NGS 3.0 release with processing improvements promise 2x speedup compared to the global benchmark March 31, 2017 | Bangalore, India Strand Life Sciences today announced the release of version…

read more

Strand Life Sciences expands onco-genomic portfolio in India with the globally benchmarked 152-gene StrandAdvantage test

150 150 Strand Life Sciences

December 20, 2016 | Bangalore, India It is vital for oncologists to get clinically actionable and timely results to decide on treatment options for patients. Keeping this in mind, StrandAdvantage,…

read more

New NGS-based approach scores high in diagnosing Retinoblastoma: Study

150 150 Strand Life Sciences

Approach proves to be six times more economical than Reflex Mode Testing November 09, 2016 | Bangalore, India  Strand Life Sciences, a genomic profiling company and leader in precision medicine…

read more